These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38273694)
21. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital. Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754 [TBL] [Abstract][Full Text] [Related]
22. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911 [TBL] [Abstract][Full Text] [Related]
23. Frontal osteomyelitis post-COVID-19 associated mucormycosis. Kulkarni P; Beeraka D; Tanwar M; Kim U; Ganesan RM; Saini P Indian J Ophthalmol; 2023 Jul; 71(7):2906-2910. PubMed ID: 37417145 [TBL] [Abstract][Full Text] [Related]
24. Mucormycosis in COVID-19 patients. Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032 [TBL] [Abstract][Full Text] [Related]
25. Orbital mucormycosis with retinal and ciliary artery occlusions. Luo QL; Orcutt JC; Seifter LS Br J Ophthalmol; 1989 Aug; 73(8):680-3. PubMed ID: 2765451 [TBL] [Abstract][Full Text] [Related]
26. Rhino-orbito-cerebral mucormycosis in an immunocompetent patient: case report and review of literature. Shatriah I; Mohd-Amin N; Tuan-Jaafar TN; Khanna RK; Yunus R; Madhavan M Middle East Afr J Ophthalmol; 2012; 19(2):258-61. PubMed ID: 22623872 [TBL] [Abstract][Full Text] [Related]
27. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review. Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206 [TBL] [Abstract][Full Text] [Related]
28. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan. Kumar S; Kumar H; Mali M; Meena BL Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339 [TBL] [Abstract][Full Text] [Related]
29. Central retinal vein occlusion as primary ocular manifestation of rhino-orbital-cerebral mucormycosis: A case report. Sethi NK; Chadha C; Bajaj M; Moond H Indian J Ophthalmol; 2022 Dec; 70(12):4451-4453. PubMed ID: 36453365 [TBL] [Abstract][Full Text] [Related]
30. Optical Coherence Tomography of Retinal Artery Occlusion Associated With Mucormycosis and COVID-19. Kaur R; Khan B; Sharma A JAMA Ophthalmol; 2021 Nov; 139(11):e214064. PubMed ID: 34787678 [No Abstract] [Full Text] [Related]
32. Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis. Sedaghattalab M; Bagheri T; Doustimotlagh AH Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975535 [TBL] [Abstract][Full Text] [Related]
33. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. Honavar SG Indian J Ophthalmol; 2021 Jun; 69(6):1361-1365. PubMed ID: 34011699 [No Abstract] [Full Text] [Related]
34. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
35. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases. Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023 [No Abstract] [Full Text] [Related]
37. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study. Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653 [TBL] [Abstract][Full Text] [Related]
38. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study. Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980 [TBL] [Abstract][Full Text] [Related]
40. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis. Yadav S; Bs N; Ak S J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]